Clinical trial
Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During…
NCT00159211 · Assistance Publique - Hôpitaux de Paris, Other · Terminated
Key facts
| NCT number | NCT00159211 |
|---|---|
| Title | Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During 6 Months With Pioglitazone or Insulin |
| Official title | Evolution of Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During 6 Months With Pioglitazone or Insulin, in Association With Metformin or Sulfonylurea. |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Collaborators | Laboratoires Takeda Industry |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Type 2 Diabetes |
| Intervention type | Drug |
| Interventions | UMULINE NPH, pioglitazone |
| Enrollment | 28 |
| Start date | May 1, 2005 |
| Completion | May 1, 2007 |
| First posted | Sep 12, 2005 |
| Last update posted | Nov 8, 2007 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: